A Study to Investigate the Interaction Between TMP-301 and Cocaine.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 4, 2025

Primary Completion Date

May 5, 2025

Study Completion Date

May 5, 2025

Conditions

Cocaine Use Disorder

Interventions

DRUG

TMP-301

Once daily \[QD\] × 14 days

DRUG

Placebo

Once daily \[QD\] × 14 days

Trial Locations (1)

Dr. Vince Clinical Research, Overland Park

All Listed Sponsors

lead

Tempero Bio, Inc.

INDUSTRY

NCT06648668 - A Study to Investigate the Interaction Between TMP-301 and Cocaine. | Biotech Hunter | Biotech Hunter